- Home
- KALA vs HOOK Comparison
KALA vs HOOK Comparison
Compare KALA & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- HOOK
- Stock Information
- Founded
- KALA 2009
- HOOK 2011
- Country
- KALA United States
- HOOK United States
- Employees
- KALA N/A
- HOOK N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- KALA Health Care
- HOOK Health Care
- Exchange
- KALA Nasdaq
- HOOK Nasdaq
- Market Cap
- KALA 27.3M
- HOOK 24.5M
- IPO Year
- KALA 2017
- HOOK 2019
- Fundamental
- Price
- KALA $6.64
- HOOK $1.78
- Analyst Decision
- KALA Strong Buy
- HOOK Buy
- Analyst Count
- KALA 2
- HOOK 4
- Target Price
- KALA $15.00
- HOOK $10.67
- AVG Volume (30 Days)
- KALA 108.1K
- HOOK 44.7K
- Earning Date
- KALA 03-28-2025
- HOOK 03-21-2025
- Dividend Yield
- KALA N/A
- HOOK N/A
- EPS Growth
- KALA N/A
- HOOK N/A
- EPS
- KALA N/A
- HOOK N/A
- Revenue
- KALA N/A
- HOOK $49,999,000.00
- Revenue This Year
- KALA N/A
- HOOK $148.80
- Revenue Next Year
- KALA N/A
- HOOK N/A
- P/E Ratio
- KALA N/A
- HOOK N/A
- Revenue Growth
- KALA N/A
- HOOK 143.30
- 52 Week Low
- KALA $4.21
- HOOK $1.65
- 52 Week High
- KALA $11.20
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- KALA 39.29
- HOOK 41.23
- Support Level
- KALA $6.50
- HOOK $1.77
- Resistance Level
- KALA $8.65
- HOOK $1.96
- Average True Range (ATR)
- KALA 0.90
- HOOK 0.12
- MACD
- KALA -0.43
- HOOK 0.00
- Stochastic Oscillator
- KALA 2.98
- HOOK 41.40
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.